Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

New hires at Brii, Ono and PharmaEssentia to strengthen U.S. leadership

Plus: Ocular, Genprex, SAB and more

September 28, 2021 9:22 PM UTC

Infectious and CNS disease company Brii Biosciences Ltd. (HKEX:2137) hired Coy Stout as SVP and head of U.S. market access and patient advocacy. Stout joins from Gilead Sciences Inc. (NASDAQ:GILD), where he worked for 17 years in several roles, most recently as VP of U.S. commercial access and reimbursement. The company went public on the Hong Kong stock exchange in July.

Ono Pharma USA Inc., the U.S. subsidiary of Ono Pharmaceutical Co. Ltd. (Tokyo:4528), hired David Trexler as chief commercial officer. Trexler, an 18-year veteran of Sanofi (Euronext:SAN; NASDAQ:SNY), was president and board member at MorphoSys US Inc., and previously held leadership roles at EMD Serono Inc., a part of Merck KGaA (Xetra:MRK)and at Eisai US...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article